BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 15081028)

  • 41. Design, synthesis, biological evaluation, NMR and DFT studies of structurally simplified trimethoxy benzamides as selective P-glycoprotein inhibitors: the role of molecular flatness.
    Stefanachi A; Mangiatordi GF; Tardia P; Alberga D; Leonetti F; Niso M; Colabufo NA; Adamo C; Nicolotti O; Cellamare S
    Chem Biol Drug Des; 2016 Dec; 88(6):820-831. PubMed ID: 27331911
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preparation of pyrrolidine and isoxazolidine benzamidines as potent inhibitors of coagulation factor Xa.
    Fevig JM; Buriak J; Stouten PF; Knabb RM; Lam GN; Wong PC; Wexler RR
    Bioorg Med Chem Lett; 1999 Apr; 9(8):1195-200. PubMed ID: 10328312
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Solid phase synthesis of benzamidine-derived sulfonamide libraries.
    Kim SW; Hong CY; Koh JS; Lee EJ; Lee K
    Mol Divers; 1997-1998; 3(2):133-6. PubMed ID: 9593184
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Solid phase synthesis of benzamidine and butylamine-derived hydantoin libraries.
    Kim SW; Koh JS; Lee EJ; Ro S
    Mol Divers; 1997-1998; 3(2):129-32. PubMed ID: 9593183
    [TBL] [Abstract][Full Text] [Related]  

  • 45. WITHDRAWN: Design, synthesis and biological evaluation of 3-substituted-4-anilinequinoline as EGFR tyrosine kinase inhibitors.
    Mao Y; Xie K; Zhu W; Li J; Xie H; Ding J; Terrett NK; Shen J; Shen J
    Bioorg Med Chem Lett; 2012 Oct; ():. PubMed ID: 24035336
    [No Abstract]   [Full Text] [Related]  

  • 46. [Generalized eczema from sensitivity to hexomedine].
    GOUGEROT H; TABERNAT J; RAUFAST ; GASCOIN
    Bull Soc Fr Dermatol Syphiligr; 1950; 57(3):271. PubMed ID: 14801571
    [No Abstract]   [Full Text] [Related]  

  • 47. Propamidine in veterinary practice.
    TRIPATHI PC
    Indian Vet J; 1946 Jul; 23(1):32-4. PubMed ID: 20341598
    [No Abstract]   [Full Text] [Related]  

  • 48. The benzamides. Pharmacology, neurobiology, and clinical aspects.
    Adv Biochem Psychopharmacol; 1982; 35():1-209. PubMed ID: 7148558
    [No Abstract]   [Full Text] [Related]  

  • 49. The antagonism between propamidine and salts.
    MASSART L
    Arch Int Pharmacodyn Ther; 1950 Feb; 81(2):243. PubMed ID: 15405460
    [No Abstract]   [Full Text] [Related]  

  • 50. Toxic reactions following the use of phenamidine (May and Baker) in the dog.
    NYE SS; CRAWSHAW HA; NICOL J
    Vet Rec; 1950 Sep; 62(36):533-4. PubMed ID: 14782371
    [No Abstract]   [Full Text] [Related]  

  • 51. A clinical evaluation of trimethobenzamide (Tigan) as an antigagging drug.
    GRACE LE; HACKNEY RD; DOBBS EC
    Oral Surg Oral Med Oral Pathol; 1963 Apr; 16():422-5. PubMed ID: 13949688
    [No Abstract]   [Full Text] [Related]  

  • 52. The Role of Clinical Nurses in Supporting DEIB Initiatives.
    Gilles SA; Crespo-Fierro M; Johnson-Campbell T
    Am J Nurs; 2024 Feb; 124(2):17. PubMed ID: 38270417
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Benzamides and benzamidines as specific inhibitors of epidermal growth factor receptor and v-Src protein tyrosine kinases.
    Asano T; Yoshikawa T; Usui T; Yamamoto H; Yamamoto Y; Uehara Y; Nakamura H
    Bioorg Med Chem; 2004 Jul; 12(13):3529-42. PubMed ID: 15186837
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and biological evaluation of bis(methoxy methyl)-7,8-dihydro-[1,4]dioxino[2,3-g]quinazolines as EGFR tyrosine kinase inhibitors.
    Lee YS; Seo SH; Yang BS; Lee JY
    Arch Pharm (Weinheim); 2005 Oct; 338(10):502-5. PubMed ID: 16211656
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design, synthesis and biological evaluation of novel pyrimidine, 3-cyanopyridine and m-amino-N-phenylbenzamide based monocyclic EGFR tyrosine kinase inhibitors.
    Mao Y; Zhu W; Kong X; Wang Z; Xie H; Ding J; Terrett NK; Shen J; Shen J
    Bioorg Med Chem; 2013 Jun; 21(11):3090-104. PubMed ID: 23602524
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery of indenopyrazoles as EGFR and VEGFR-2 tyrosine kinase inhibitors by in silico high-throughput screening.
    Usui T; Ban HS; Kawada J; Hirokawa T; Nakamura H
    Bioorg Med Chem Lett; 2008 Jan; 18(1):285-8. PubMed ID: 17983745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and biological evaluation of benzamides and benzamidines: structural requirement of a pyrimidine ring for inhibition of EGFR tyrosine kinase.
    Asano T; Yoshikawa T; Nakamura H; Uehara Y; Yamamoto Y
    Bioorg Med Chem Lett; 2004 May; 14(9):2299-302. PubMed ID: 15081028
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis and biological evaluation of benzamides and benzamidines as selective inhibitors of VEGFR tyrosine kinases.
    Nakamura H; Sasaki Y; Uno M; Yoshikawa T; Asano T; Ban HS; Fukazawa H; Shibuya M; Uehara Y
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5127-31. PubMed ID: 16893647
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.